Open official notice

The VerifyNow P2Y12 Test is designed to measure platelet P2Y12 receptor blockade. Substances known to specifically block the P2Y12 receptor

Official notice

1 Jun 2022

RecallScope risk estimate:MediumFDA

An official FDA notice concerns The VerifyNow P2Y12 Test is designed to measure platelet P2Y12 receptor blockade. Substances known to specifically block the P2Y12 receptor. Two whole blood Platelet Reactivity tests exist that share the same reagent formulation and are used to obtain P2Y12 Reactivity Unit results. The test without US-FDA market clearance was distributed and it displays BASE results not displayed by the US-FDA market cleared device. A formula is being provided to health care personnel to calculate the percentage of platelet aggregation inhibition. Published 2022-06-01.

What to do now

This recall has been terminated. See the official FDA notice for the latest status.

Units affected

11

Recall number

Z-1121-2022

Official notice

2022-06-01

The hazard

Two whole blood Platelet Reactivity tests exist that share the same reagent formulation and are used to obtain P2Y12 Reactivity Unit results. The test without US-FDA market clearance was distributed and it displays BASE results not displayed by the US-FDA market cleared device. A formula is being provided to health care personnel to calculate the percentage of platelet aggregation inhibition.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

WL1060

Event Ids

89936

Recall Numbers

Z-1121-2022

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

The VerifyNow P2Y12 Test is designed to measure platelet P2Y12 receptor blockade. Substances known to specifically block the P2Y12 receptor include ticagrelor and the thienopyridine class of drugs, including clopidogrel and prasugrel.1-8 The test is based upon the ability of activated platelets to bind fibrinogen. Fibrinogen-coated microparticles aggregate in whole blood in proportion to the number of expressed platelet GP IIb/IIIa receptors. Light transmittance increases as activated platelets bind and aggregate fibrinogen-coated beads. The instrument measures this change in optical signal and reports results in P2Y12 Reaction Units (PRU). The rate of microbead aggregation is more rapid and reproducible if platelets are activated; therefore, the reagent adenosine-5-diphosphate (ADP) is incorporated into the test channel to induce platelet activation. Prostaglandin E1 (PGE1) is included in the reagent mixture to increase the specificity of the PRU result to reflect P2Y12-mediated platelet aggregation. The reagents are formulated such to achieve reaction concentrations of 20 ¿M ADP and 22 nM PGE1. In a like manner, two other activators, iso-TRAP (Thrombin Receptor Activating Peptide) with PAR4-AP (PAR4-Activating Peptide) and fibrinogen-coated microparticles are incorporated into a second channel of the test device. The instrument measures the change in transmittance in this channel, calculates the baseline platelet function for the sample, and reports the percent inhibition result for the sample.

Units affected

11

Hazard

Two whole blood Platelet Reactivity tests exist that share the same reagent formulation and are used to obtain P2Y12 Reactivity Unit results. The test without US-FDA market clearance was distributed and it displays BASE results not displayed by the US-FDA market cleared device. A formula is being provided to health care personnel to calculate the percentage of platelet aggregation inhibition.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Accriva Diagnostics, Inc.

Phone

Not provided

Brand: Accriva Diagnostics. Contact: Accriva Diagnostics, Inc..

Source & status

Source

Tier

official

Category

Tech & Electronics

Official classification

Class II

Recall details

Recall number

Z-1121-2022

Event ID

89936

Units affected

11

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 1 Jun 2022. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button